M. Debled
Impact in
-
- Breast Cancer Treatment Studies
-
- HER2/EGFR in Cancer Research
- Cancer Risks and Factors
- Cancer Treatment and Pharmacology
Papers in
- Oncology 11
- Cancer Treatment and Pharmacology 6
- HER2/EGFR in Cancer Research 2
- Cancer Diagnosis and Treatment 2
- Cancer Risks and Factors 2
-
- Advanced Breast Cancer Therapies 5
- Co-authors
- L. Mauriac (7 shared papers)G. Le Bouëdec (1 shared paper)Jean-Marc Ferrero (2 shared papers)G. Lorimier (1 shared paper)Gaëtan MacGrogan (3 shared papers)J.M. Classe (1 shared paper)Simone Mathoulin‐Pélissier (1 shared paper)A. Avril (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Cancer Research (3 papers)Critical Reviews in Oncology/Hematology (2 papers)European Journal of Cancer (1 paper)European Journal of Surgical Oncology (1 paper)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
M. Debled
15 papers receiving 82 citations
Peers
Comparison fields: 5 of 26
- Cancer Research 50
- Oncology 57
- Pathology and Forensic Medicine 16
- Genetics 18
- Geriatrics and Gerontology 2
Countries citing papers authored by M. Debled
This map shows the geographic impact of M. Debled's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Debled with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Debled more than expected).
Fields of papers citing papers by M. Debled
This network shows the impact of papers produced by M. Debled. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Debled. The network helps show where M. Debled may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Debled, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 22 | |
| 2 | 2011 | 16 | |
| 3 | 2021 | 14 | |
| 4 | 2006 | 10 | |
| 5 | 2008 | 5 | |
| 6 | 2006 | 5 | |
| 7 | [Role of adjuvant chemotherapy in the treatment of soft tissue sarcoma]. | 1997 | 2 |
| 8 | 2016 | 2 | |
| 9 | 2010 | 2 | |
| 10 | 2006 | 2 | |
| 11 | [Primary intraosseous rhabdomyosarcoma]. | 2000 | 1 |
| 12 | 2005 | 1 | |
| 13 | 2009 | 1 | |
| 14 | 2008 | 1 | |
| 15 | 2010 | 1 | |
| 16 | 2009 | 0 |
About M. Debled
M. Debled is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Epidemiology, having authored 16 papers that have together received 85 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Breast Cancer Treatment Studies (5 papers), Advanced Breast Cancer Therapies (5 papers), Estrogen and related hormone effects (4 papers), HER2/EGFR in Cancer Research (2 papers), Cancer Diagnosis and Treatment (2 papers), Cancer Risks and Factors (2 papers) and Multiple and Secondary Primary Cancers (2 papers). The work is most often cited by research in Cancer Research (50 citations), Oncology (57 citations), Pathology and Forensic Medicine (16 citations), Genetics (18 citations) and Geriatrics and Gerontology (2 citations). M. Debled has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include L. Mauriac, G. Le Bouëdec, Jean-Marc Ferrero, G. Lorimier, Gaëtan MacGrogan, J.M. Classe, Simone Mathoulin‐Pélissier, A. Avril, S. Giard and Catherine Loustalot. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Critical Reviews in Oncology/Hematology, European Journal of Cancer and European Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.